Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs.
about
CD8(+) T cells mediate robust stage-specific immunity to P. berghei under chemoprophylaxis and this protective environment is not downregulated by the presence of blood-stage infectionAntimalarial activities and subacute toxicity of RC-12, a 4-amino-substituted pyrocatechol.Development of new derivatives of primaquine by association with lysosomotropic carriers.CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii.Correlates of protective immunity following whole sporozoite vaccination against malaria.New tissue schizontocidal antimalarial drugs.
P2860
Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年論文
@yue
1974年論文
@zh-hant
1974年論文
@zh-hk
1974年論文
@zh-mo
1974年論文
@zh-tw
1974年论文
@wuu
1974年论文
@zh
1974年论文
@zh-cn
name
Assessment of causal prophylac ...... ent of new antimalarial drugs.
@en
type
label
Assessment of causal prophylac ...... ent of new antimalarial drugs.
@en
prefLabel
Assessment of causal prophylac ...... ent of new antimalarial drugs.
@en
P921
P1476
Assessment of causal prophylac ...... ent of new antimalarial drugs.
@en
P2093
P304
P407
P577
1974-01-01T00:00:00Z